Please note: Items that appear in the Community Postings section are submitted by visitors. Posts are reviewed to ensure they are appropriate for our audience, but typically are not edited by University Marketing and Communications.
Medtech company with ties to CWRU, UH completes $70 million IPO
Crain’s Cleveland Business: Sanford Markowitz, the Ingalls Professor of Cancer Genetics and Medicine at the School of Medicine, discussed the $70 million initial public offering of Lucid Diagnostics, a company that makes esophageal cancer tests, developed by faculty at the School of Medicine and University Hospitals.
